These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 515575)

  • 21. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of D-penicillamine on circulating protein complexes in rheumatoid arthritis and primary biliary cirrhosis.
    Wollheim FA
    J Rheumatol Suppl; 1981; 7():74-9. PubMed ID: 7014877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penicillamine compared to previous chrysotherapy in rheumatoid arthritis.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    J Rheumatol; 1983 Apr; 10(2):319-22. PubMed ID: 6864688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of rheumatoid hyperviscosity syndrome with characterization of the serum immune complexes.
    Silberman S; Holmes EW; Miller BJ; Messmore HL; Barr WG
    Ann Clin Lab Sci; 1986; 16(1):26-33. PubMed ID: 3947026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Are antinuclear factors a contraindication for penicillamine treatment in patients with rheumatoid arthritis? (author's transl)].
    Scherak O; Hiesberger H; Kolarz G
    Wien Klin Wochenschr; 1978 Feb; 90(3):95-6. PubMed ID: 304637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penicillamine in the treatment of rheumatoid arthritis.
    Camp AV
    Proc R Soc Med; 1977 Feb; 70(2):67-9. PubMed ID: 859814
    [No Abstract]   [Full Text] [Related]  

  • 28. Rheumatoid factors and HLA-DR4 in RA.
    Emery P; Panayi GS; Welsh KI; Cole BC
    J Rheumatol; 1985 Apr; 12(2):217-22. PubMed ID: 3875716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of D-penicillamine on the immunological indices of rheumatoid arthritis patients].
    Sheĭtanov I
    Vutr Boles; 1990; 29(4):59-64. PubMed ID: 2281661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response.
    Situnayake RD; McConkey B
    J Rheumatol; 1990 Oct; 17(10):1268-73. PubMed ID: 1979349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of D-penicillamine on serum immunoglobulins in rheumatoid arthritis].
    Gambari PF; Mioni E; Ostuni A; Volante D; Punzi L; Todesco S; Ongaro G
    Boll Soc Ital Biol Sper; 1981 May; 57(10):1127-31. PubMed ID: 6794580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of penicillamine therapy on circulating immune complexes in rheumatoid arthritis.
    Mohammed I; Barraclough D; Holborow EJ; Ansell BM
    Ann Rheum Dis; 1975 Oct; 35(5):458-62. PubMed ID: 1086655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Circulating immune complexes in malignant rheumatoid arthritis].
    Ezaki I
    Ryumachi; 1983 Oct; 23(5):327-39. PubMed ID: 6673157
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug effects on autoantibodies and immune complexes.
    Holborow EJ
    Agents Actions Suppl; 1980; 7():58-61. PubMed ID: 6972690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expanded clinical and basic profile of rheumatoid factors. 3. IgG subclasses participating in the formation of abnormal immune complexes in RA].
    Yoshinoya S; Takahashi K; Miyamoto A
    Ryumachi; 1988 Dec; 28(6):419-22. PubMed ID: 3249978
    [No Abstract]   [Full Text] [Related]  

  • 36. Some aspects of slow-acting drugs in rheumatoid arthritis.
    Ansell BM
    Agents Actions Suppl; 1979; (5):111-9. PubMed ID: 294130
    [No Abstract]   [Full Text] [Related]  

  • 37. Upper and lower airway disease in penicillamine treated patients with rheumatoid arthritis.
    Wolfe F; Schurle DR; Lin JJ; Polland SM; Smith TW; Montgomery-Short R; James DL
    J Rheumatol; 1983 Jun; 10(3):406-10. PubMed ID: 6887164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.
    Scott DG; Bacon PA; Allen C; Elson CJ; Wallington T
    Clin Exp Immunol; 1981 Jan; 43(1):54-63. PubMed ID: 7249394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penicillamine in rheumatoid disease.
    Thrift EG; Lewis B
    Aust Fam Physician; 1983 Dec; 12(12):870-1. PubMed ID: 6670953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ceruloplasmin and immunoglobulins under controlled D-penicillamine therapy in rheumatoid arthritis].
    Schmidt KL; Ott VR
    Z Rheumatol; 1976; 35(3-4):154-63. PubMed ID: 1266422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.